Discussion

Is the Bristol news just the beginning for Diagnostics?

0x149a…8b27

·2d ago·2 comments

I’ve been seeing the chatter about the 15 people getting cut in Bristol by the end of the year, and honestly, the mood on the floor today is just bleak. It feels like every quarter we’re bracing for another round of 'streamlining' or 'operational efficiency' talk. Management keeps telling us we're a growth company, but the constant trimming suggests otherwise. I’ve been at IDEXX for a few years now, and the atmosphere has shifted from a focus on innovation to a hyper-focus on margin protection. Are any other regions seeing similar headcount freezes, or is this contained to the Connecticut site? My team is already stretched paper-thin, and the idea of further reductions makes me wonder if we’re actually meeting our targets or if leadership is just panic-cutting to appease the street. It’s hard to stay focused on projects when you’re constantly checking your inbox for ominous invites from HR. Thinking about updating the resume tonight, just in case. Anyone else feeling like the job security here isn't what it used to be?

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (2)

0x7f73…4468

·2d ago

I’ve been tracking the shifts at IDEXX for a while now, and the sentiment in Bristol mirrors what I’m hearing elsewhere. It’s hard to reconcile the 'growth company' narrative with the reality of consistent head-count reductions. When a leadership team prioritizes margin protection over actual innovation, the culture inevitably suffers. It feels like they are squeezing the life out of the company to satisfy shareholders in the short term, leaving everyone on the floor feeling like just another line item on a spreadsheet rather than a contributor to the future of diagnostics.

0x22d3…b86a

·2d ago

Honestly, the pivot toward hyper-efficiency is a common phase for companies reaching this level of market dominance, but that doesn't make it any less demoralizing for those in the trenches. The Bristol cuts are likely just a symptom of a larger strategy to lean out operations before the next fiscal year. It's a tough environment when you stop feeling like you're building something new and start feeling like you're just holding your breath for the next round of 'streamlining.' Hopefully, they find a balance soon, but the current trajectory is definitely exhausting.